Advertisement
DGX vs SNN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGX is a Hold and SNN is a StrongBuy.
DGX in upward trend: price rose above 50-day moving average on October 20, 2026
DGX moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend. In 36 of 47 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 77%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on DGX as a result. In 65 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.
The Moving Average Convergence Divergence (MACD) for DGX just turned positive on October 15, 2026. Looking at past instances where DGX's MACD turned positive, the stock continued to rise in 27 of 42 cases over the following month. The odds of a continued upward trend are 64%.
Following a +1.71% 3-day Advance, the price is estimated to grow further. Considering data from situations where DGX advanced for three days, in 195 of 311 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 10-day moving average for DGX crossed bearishly below the 50-day moving average on October 01, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 39%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DGX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 44%.
DGX broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 8 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.509) is normal, around the industry mean (64.450). P/E Ratio (25.045) is within average values for comparable stocks, (2.086). Projected Growth (PEG Ratio) (1.546) is also within normal values, averaging (3.473). DGX's Dividend Yield (0.014) is considerably higher than the industry average of (0.002). P/S Ratio (2.404) is also within normal values, averaging (9.775).
The Tickeron Profit vs. Risk Rating rating for this company is 17 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 29 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. DGX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 58 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
SNN's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for SNN turned positive on October 05, 2026. Looking at past instances where SNN's MACD turned positive, the stock continued to rise in 34 of 50 cases over the following month. The odds of a continued upward trend are 68%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 07, 2026. You may want to consider a long position or call options on SNN as a result. In 50 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 60%.
SNN moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for SNN crossed bullishly above the 50-day moving average on October 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 53%.
Following a +4.42% 3-day Advance, the price is estimated to grow further. Considering data from situations where SNN advanced for three days, in 192 of 333 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SNN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 57%.
SNN broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for SNN entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.362) is normal, around the industry mean (2.923). P/E Ratio (19.697) is within average values for comparable stocks, (2.388). Projected Growth (PEG Ratio) (1.035) is also within normal values, averaging (11.052). Dividend Yield (0.041) settles around the average of (0.009) among similar stocks. P/S Ratio (1.905) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating steady price growth. SNN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 83 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SNN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
DGX | SNN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 14 | 33 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 8 Undervalued | 15 Undervalued | |
PROFIT vs RISK RATING 1..100 | 17 | 100 | |
SMR RATING 1..100 | 58 | 92 | |
PRICE GROWTH RATING 1..100 | 42 | 55 | |
P/E GROWTH RATING 1..100 | 29 | 83 | |
SEASONALITY SCORE 1..100 | 85 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
DGX's Valuation (8) in the Servicestothe Health Industry industry is in the same range as SNN (15) in the Medical Specialties industry. This means that DGX’s stock grew similarly to SNN’s over the last 12 months.
DGX's Profit vs Risk Rating (17) in the Servicestothe Health Industry industry is significantly better than the same rating for SNN (100) in the Medical Specialties industry. This means that DGX’s stock grew significantly faster than SNN’s over the last 12 months.
DGX's SMR Rating (58) in the Servicestothe Health Industry industry is somewhat better than the same rating for SNN (92) in the Medical Specialties industry. This means that DGX’s stock grew somewhat faster than SNN’s over the last 12 months.
DGX's Price Growth Rating (42) in the Servicestothe Health Industry industry is in the same range as SNN (55) in the Medical Specialties industry. This means that DGX’s stock grew similarly to SNN’s over the last 12 months.
DGX's P/E Growth Rating (29) in the Servicestothe Health Industry industry is somewhat better than the same rating for SNN (83) in the Medical Specialties industry. This means that DGX’s stock grew somewhat faster than SNN’s over the last 12 months.
| DGX | SNN | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 53% |
| Stochastic ODDS (%) | 2 days ago 45% | 2 days ago 54% |
| Momentum ODDS (%) | 2 days ago 76% | 2 days ago 60% |
| MACD ODDS (%) | 2 days ago 64% | 2 days ago 68% |
| TrendWeek ODDS (%) | 2 days ago 62% | 2 days ago 56% |
| TrendMonth ODDS (%) | 2 days ago 39% | 2 days ago 58% |
| Advances ODDS (%) | 2 days ago 63% | 8 days ago 58% |
| Declines ODDS (%) | 4 days ago 44% | 4 days ago 57% |
| BollingerBands ODDS (%) | 2 days ago 57% | 2 days ago 56% |
| Aroon ODDS (%) | N/A | 2 days ago 60% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DGX’s FA Score shows that 3 FA rating(s) are green while SNN’s FA Score has 1 green FA rating(s).
- DGX’s FA Score: 3 green, 2 red.
- SNN’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DGX’s TA Score shows that 4 TA indicator(s) are bullish while SNN’s TA Score has 5 bullish TA indicator(s).
- DGX’s TA Score: 4 bullish, 4 bearish.
- SNN’s TA Score: 5 bullish, 5 bearish.
Price Growth
DGX (@Medical Specialties) experienced а +2.36% price change this week, while SNN (@Medical/Nursing Services) price change was +4.84% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -3.15%. For the same industry, the average monthly price growth was -6.50%, and the average quarterly price growth was +42.74%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.
Reported Earning Dates
DGX is expected to report earnings on Oct 22, 2026.
SNN is expected to report earnings on Nov 04, 2026.
Industries' Descriptions
@Medical Specialties (-3.15% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Medical/Nursing Services (-1.62% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
DGX and
Correlation & Price change
A.I.dvisor indicates that over the last year, DGX has been closely correlated with LH. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if DGX jumps, then LH could also see price increases.